Cargando…
Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe
Mitochondria are the main fascinating energetic source into the cells. Their number, shape, and dynamism are controlled by the cell’s type and current behavior. The perturbation of the mitochondrial inward system via stress response and/or oncogenic insults could activate several trafficking molecul...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312164/ https://www.ncbi.nlm.nih.gov/pubmed/32486249 http://dx.doi.org/10.3390/ijms21113928 |
_version_ | 1783549667762503680 |
---|---|
author | Panuzzo, Cristina Jovanovski, Aleksandar Pergolizzi, Barbara Pironi, Lucrezia Stanga, Serena Fava, Carmen Cilloni, Daniela |
author_facet | Panuzzo, Cristina Jovanovski, Aleksandar Pergolizzi, Barbara Pironi, Lucrezia Stanga, Serena Fava, Carmen Cilloni, Daniela |
author_sort | Panuzzo, Cristina |
collection | PubMed |
description | Mitochondria are the main fascinating energetic source into the cells. Their number, shape, and dynamism are controlled by the cell’s type and current behavior. The perturbation of the mitochondrial inward system via stress response and/or oncogenic insults could activate several trafficking molecular mechanisms with the intention to solve the problem. In this review, we aimed to clarify the crucial pathways in the mitochondrial system, dissecting the different metabolic defects, with a special emphasis on hematological malignancies. We investigated the pivotal role of mitochondria in the maintenance of hematopoietic stem cells (HSCs) and their main alterations that could induce malignant transformation, culminating in the generation of leukemic stem cells (LSCs). In addition, we presented an overview of LSCs mitochondrial dysregulated mechanisms in terms of (1) increasing in oxidative phosphorylation program (OXPHOS), as a crucial process for survival and self-renewal of LSCs,(2) low levels of reactive oxygen species (ROS), and (3) aberrant expression of B-cell lymphoma 2 (Bcl-2) with sustained mitophagy. Furthermore, these peculiarities may represent attractive new “hot spots” for mitochondrial-targeted therapy. Finally, we remark the potential of the LCS metabolic effectors to be exploited as novel therapeutic targets. |
format | Online Article Text |
id | pubmed-7312164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73121642020-06-26 Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe Panuzzo, Cristina Jovanovski, Aleksandar Pergolizzi, Barbara Pironi, Lucrezia Stanga, Serena Fava, Carmen Cilloni, Daniela Int J Mol Sci Review Mitochondria are the main fascinating energetic source into the cells. Their number, shape, and dynamism are controlled by the cell’s type and current behavior. The perturbation of the mitochondrial inward system via stress response and/or oncogenic insults could activate several trafficking molecular mechanisms with the intention to solve the problem. In this review, we aimed to clarify the crucial pathways in the mitochondrial system, dissecting the different metabolic defects, with a special emphasis on hematological malignancies. We investigated the pivotal role of mitochondria in the maintenance of hematopoietic stem cells (HSCs) and their main alterations that could induce malignant transformation, culminating in the generation of leukemic stem cells (LSCs). In addition, we presented an overview of LSCs mitochondrial dysregulated mechanisms in terms of (1) increasing in oxidative phosphorylation program (OXPHOS), as a crucial process for survival and self-renewal of LSCs,(2) low levels of reactive oxygen species (ROS), and (3) aberrant expression of B-cell lymphoma 2 (Bcl-2) with sustained mitophagy. Furthermore, these peculiarities may represent attractive new “hot spots” for mitochondrial-targeted therapy. Finally, we remark the potential of the LCS metabolic effectors to be exploited as novel therapeutic targets. MDPI 2020-05-30 /pmc/articles/PMC7312164/ /pubmed/32486249 http://dx.doi.org/10.3390/ijms21113928 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Panuzzo, Cristina Jovanovski, Aleksandar Pergolizzi, Barbara Pironi, Lucrezia Stanga, Serena Fava, Carmen Cilloni, Daniela Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe |
title | Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe |
title_full | Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe |
title_fullStr | Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe |
title_full_unstemmed | Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe |
title_short | Mitochondria: A Galaxy in the Hematopoietic and Leukemic Stem Cell Universe |
title_sort | mitochondria: a galaxy in the hematopoietic and leukemic stem cell universe |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312164/ https://www.ncbi.nlm.nih.gov/pubmed/32486249 http://dx.doi.org/10.3390/ijms21113928 |
work_keys_str_mv | AT panuzzocristina mitochondriaagalaxyinthehematopoieticandleukemicstemcelluniverse AT jovanovskialeksandar mitochondriaagalaxyinthehematopoieticandleukemicstemcelluniverse AT pergolizzibarbara mitochondriaagalaxyinthehematopoieticandleukemicstemcelluniverse AT pironilucrezia mitochondriaagalaxyinthehematopoieticandleukemicstemcelluniverse AT stangaserena mitochondriaagalaxyinthehematopoieticandleukemicstemcelluniverse AT favacarmen mitochondriaagalaxyinthehematopoieticandleukemicstemcelluniverse AT cillonidaniela mitochondriaagalaxyinthehematopoieticandleukemicstemcelluniverse |